You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Flt3l

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Prognostic Stage IV Breast Cancer AJCC v8 Trial in Los

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +5 more
  • Anti-CD40 Agonist Monoclonal Antibody CDX-1140
  • +3 more
  • Los Angeles, California
    USC/Norris Comprehensive Cancer Center
Jan 31, 2023

Non-Hodgkin's Lymphoma, Metastatic Breast Cancer, Head and Neck Squamous Cell Carcinoma Trial in New York (Pembrolizumab, Flt3L,

Recruiting
  • Non-Hodgkin's Lymphoma
  • +2 more
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Oct 18, 2021

Cutaneous Melanoma, Melanoma, Melanoma of Unknown Primary Trial in United States (DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly

Completed
Has Results
  • Cutaneous Melanoma
  • +11 more
  • DEC-205/NY-ESO-1 Fusion Protein CDX-1401
  • +2 more
  • Chicago, Illinois
  • +6 more
Nov 10, 2021

Malignant Glioma, Glioblastoma Multiforme Trial in Ann Arbor (Dose Escalation of Ad-hCMV-TK and Ad-hCMV-Flt3L)

Completed
  • Malignant Glioma
  • Glioblastoma Multiforme
  • Dose Escalation of Ad-hCMV-TK and Ad-hCMV-Flt3L
  • Ann Arbor, Michigan
    University of Michigan Health System Department of Neurosurgery
Aug 25, 2021

Low-Grade B-cell Lymphoma Trial in New York (rhuFlt3L/CDX-301, Poly-ICLC)

Recruiting
  • Low-Grade B-cell Lymphoma
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Nov 17, 2020

Advanced Cancers Trial in Houston (PET Scan, FLT)

Active, not recruiting
  • Advanced Cancers
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 16, 2022

Acute Myeloid Leukemia With FLT3/ITD Mutation Trial (XY0206, Salvage Chemotherapy)

Not yet recruiting
  • Acute Myeloid Leukemia With FLT3/ITD Mutation
  • (no location specified)
May 24, 2023

Acute Myeloid Leukemia With FLT3/ITD Mutation Trial in Tampa (Gilteritinib, Vyxeos)

Suspended
  • Acute Myeloid Leukemia With FLT3/ITD Mutation
  • Tampa, Florida
    Moffitt Cancer Center
Nov 11, 2022

The Gut Microbiome in FLT3-ITD+ AML Undergoing Allo-HSCT With Or

Recruiting
  • Acute Myeloid Leukemia With FLT3/ITD Mutation
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
Oct 25, 2022

The Gut Microbiome and Sorafenib Maintenance Therapy in FLT3-ITD

Recruiting
  • Acute Myeloid Leukemia With FLT3/ITD Mutation
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
Oct 25, 2022

Acute Myeloid Leukemia Trial in Wuhan (Fludarabine + Cyclophosphamide + TAA05 Cell Injection)

Recruiting
  • Acute Myeloid Leukemia
  • Fludarabine + Cyclophosphamide + TAA05 Cell Injection
  • Wuhan, Hubei, China
    Wuhan Union Hospital
Jun 29, 2022

The Gut Microbiome in FLT3- AL Undergoing Allo-HSCT With Or

Recruiting
  • Acute Leukemia
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
Oct 28, 2022

Acute Myeloid Leukemia Trial (Gilteritinib 40 MG Oral Tablet, Cladribine, Cytarabine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Gilteritinib 40 MG Oral Tablet
  • +4 more
  • Lexington, Kentucky
    University of Kentucky
Oct 27, 2022

Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory Trial in Boston (Iadademstat, Gilteritinib Oral Tablet)

Recruiting
  • Acute Myeloid Leukemia, in Relapse
  • Acute Myeloid Leukemia Refractory
  • Boston, Massachusetts
  • +2 more
Jan 18, 2023

Pancreatic Adenocarcinoma Trial in Dallas (drug, procedure, other)

Completed
Has Results
  • Pancreatic Adenocarcinoma
  • 3'-deoxy-3'-[F-18] fluorothymidine: [F-18]FLT
  • +3 more
  • Dallas, Texas
    UT Southwestern Medical Center
Oct 10, 2022

FLT3-ITD Gene Mutation and CD135 Expression in Acute Myeloid

Not yet recruiting
  • Acute Myeloid Leukemia
    • (no location specified)
    May 17, 2022

    AML, Adult, Refractory AML, Relapsed Adult AML Trial in France (AzaCITIDine Oral Tablet, Xospata)

    Not yet recruiting
    • AML, Adult
    • +4 more
    • Amiens, France
    • +19 more
    Sep 1, 2023

    FLT-PET / MRI Brain Mets

    Recruiting
    • Brain Metastases
    • Radionecrosis
      • Toronto, Ontario, Canada
        University Health Network
      Oct 6, 2022

      Acute Myeloid Leukemia (AML), Acute Myeloid Leukemia With FMS-like Tyrosine Kinase 3 (FLT3) Mutation / Internal Tandem

      Recruiting
      • Acute Myeloid Leukemia (AML)
      • Acute Myeloid Leukemia With FMS-like Tyrosine Kinase 3 (FLT3) Mutation / Internal Tandem Duplication (ITD)
      • Cincinnati, Ohio
      • +18 more
      Jan 20, 2023

      Acute Myeloid Leukemia Trial in Suzhou (anti-FLT3 CAR-T)

      Recruiting
      • Acute Myeloid Leukemia
      • anti-FLT3 CAR-T
      • Suzhou, Jiangsu, China
        The First Affiliated Hospital of Soochow University
      Dec 29, 2021

      FLT3-positive Relapsed/Refractory Acute Myeloid Leukemia Trial in Wuhan (T cell injection targeting FLT3 chimeric antigen

      Recruiting
      • FLT3-positive Relapsed/Refractory Acute Myeloid Leukemia
      • T cell injection targeting FLT3 chimeric antigen receptor
      • Wuhan, Hubei, China
        Union Hospital, affiliated with TongJi Medical College, HuaZhong
      Jun 20, 2022

      Co-existing Mutations on Sorafenib Maintenance Therapy After

      Completed
      • Acute Myeloid Leukemia
      • +2 more
      • Guangzhou, Guangdong, China
        Department of Hematology,Nanfang Hospital, Southern Medical Univ
      May 30, 2022

      NSCLC (NSCLC) Trial in Bronx (FLT3 Ligand Therapy (CDX-301), Stereotactic Body Radiotherapy (SBRT))

      Active, not recruiting
      • Non-small Cell Lung Cancer (NSCLC)
      • FLT3 Ligand Therapy (CDX-301)
      • Stereotactic Body Radiotherapy (SBRT)
      • Bronx, New York
        Montefiore Medical Center
      Nov 5, 2021

      AML, Adult Trial in Berne (HDM201, Midostaurin)

      Terminated
      • AML, Adult
      • Berne, Switzerland
        Departement of Medical Oncology, University Hospital Berne
      Oct 3, 2022

      Leukemia, Acute Myeloid (AML) Trial (Clifutinib, LoDAC, Azacitidine)

      Not yet recruiting
      • Leukemia, Acute Myeloid (AML)
      • (no location specified)
      Oct 16, 2022